Journal ArticleAnn Surg Oncol · January 2026
BACKGROUND: De-escalation of axillary surgery for hormone receptor-positive breast cancer has gained traction, but guidelines for axillary management after neoadjuvant endocrine therapy (NET) remain ill-defined. METHODS: Female patients age ≥50 years with ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · November 23, 2025
BACKGROUND: National recommendations since 2004 have allowed for omission of post-lumpectomy radiotherapy for patients ≥70 years old with early-stage estrogen receptor positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer. ...
Full textLink to itemCite
ConferenceClinical Cancer Research · June 13, 2025
AbstractBackground: Breast cancer is increasingly prevalent in women over 65, and most are diagnosed with hormone receptor positive disease. While younger patients with early-stage breast cancer are treated ...
Full textCite
Journal ArticleAnn Surg Oncol · June 6, 2025
BACKGROUND: We examined whether adjuvant radiation therapy (RT) monotherapy offers comparable overall survival (OS) to adjuvant endocrine therapy (ET) monotherapy following lumpectomy in women aged ≥ 65 years with favorable early stage breast cancer. PATIE ...
Full textLink to itemCite
Journal ArticleCancer · May 15, 2025
PURPOSE: Improvements in systemic therapy have resulted in significant heterogeneity in survival outcomes for metastatic breast cancer patients. As such, recently proposed staging guidelines for de novo metastatic breast cancer stratify patients into four ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · December 2024
BACKGROUND: Older breast cancer patients represent a heterogeneous population. Studies demonstrate that sentinel lymph node biopsy (SLNB) omission may be appropriate in some clinical scenarios, yet patients with triple-negative breast cancer (TNBC) are oft ...
Full textLink to itemCite
ConferenceAnn Surg Oncol · November 2024
BACKGROUND: Patients with inflammatory breast cancer (IBC) have worse survival compared with stage III non-IBC matched cohorts; however, the prognostic significance of achieving pathologic complete response (pCR) in the setting of IBC is not well described ...
Full textLink to itemCite
Journal ArticleJ Surg Res · October 2024
INTRODUCTION: Stage III breast cancer is defined as locally advanced breast cancer and is treated with curative intent. Historically, overall survival (OS) did not differ based on treatment sequence (neoadjuvant chemotherapy [NAC] followed by surgery versu ...
Full textLink to itemCite
Journal ArticleLancet Digit Health · July 2024
BACKGROUND: Pulmonary complications are the most common cause of death after surgery. This study aimed to derive and externally validate a novel prognostic model that can be used before elective surgery to estimate the risk of postoperative pulmonary compl ...
Full textLink to itemCite
Journal ArticleJ Surg Res · April 2024
INTRODUCTION: With the increasing utilization of genomic assays, such as the Oncotype DX recurrence score (RS), the relevance of anatomic staging has been questioned for select older patients with breast cancer. We sought to evaluate differences in chemoth ...
Full textLink to itemCite
Journal ArticleProc (Bayl Univ Med Cent) · 2024
Physicians, and specifically surgeons, have unique expectations and responsibilities regarding professionalism. Further, surgeons interact with multiple different groups of people including surgical peers, trainees, other physicians, ancillary care partner ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · October 2023
BACKGROUND: Benefits of a pathologic complete response (pCR) following neoadjuvant therapy are well established, yet outcomes for older women are understudied. We sought to examine the pCR and overall survival (OS) rates of women with estrogen receptor (ER ...
Full textLink to itemCite
ConferenceAnn Surg Oncol · October 2022
BACKGROUND: Multiple studies have demonstrated a link between obesity and breast cancer; however, the potential association between obesity and atypical high-risk breast lesions has not been well characterized. We sought to evaluate the characteristics and ...
Full textLink to itemCite
ConferenceCancer · March 1, 2022
BACKGROUND: Asian women with breast cancer are often studied in aggregate, belying significant intragroup diversity. The authors sought to examine differences in breast cancer characteristics and outcomes among Asian women. METHODS: Asian, non-Hispanic Bla ...
Full textLink to itemCite
Journal ArticleCancer Med · February 2022
BACKGROUND: Controversy exists regarding the optimal sequence of chemotherapy among women with operable node-negative breast cancers with high-risk tumor biology. We evaluated national patterns of neoadjuvant chemotherapy (NACT) use among women with early- ...
Full textLink to itemCite
Journal ArticleAm J Surg · January 2022
BACKGROUND: We sought to identify characteristics of metastatic breast cancer (MBC) patients who may benefit most from primary tumor resection. METHODS: Recursive partitioning analysis (RPA) was used to categorize non-surgical patients with de novo MBC in ...
Full textLink to itemCite
Journal ArticleBr J Surg · December 1, 2021
BACKGROUND: This study aimed to determine the impact of pulmonary complications on death after surgery both before and during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. METHODS: This was a patient-level, comparative analysis ...
Full textLink to itemCite
ConferenceAnn Surg Oncol · November 2021
BACKGROUND: Although metastatic breast cancer (MBC) remains incurable, advances in therapies have improved survival. Using a contemporary dataset of de novo MBC patients, we explore how overall (OS) and cancer-specific survival (CSS) changed over time. MET ...
Full textLink to itemCite
Journal ArticleLancet Oncol · November 2021
BACKGROUND: Surgery is the main modality of cure for solid cancers and was prioritised to continue during COVID-19 outbreaks. This study aimed to identify immediate areas for system strengthening by comparing the delivery of elective cancer surgery during ...
Full textLink to itemCite
ConferenceAnn Surg Oncol · October 2021
BACKGROUND: Breast surgery carries a low risk of postoperative mortality. For older patients with multiple comorbidities, even low-risk procedures can confer some increased perioperative risk. We sought to identify factors associated with postoperative mor ...
Full textLink to itemCite
ConferenceCancer · July 15, 2021
BACKGROUND: The North Carolina Breast and Cervical Cancer Control Program (NC BCCCP) provides breast cancer screening services to underserved women to mitigate disparities in access to care. The authors sought to characterize this understudied population. ...
Full textLink to itemCite
Journal ArticleBr J Surg · January 27, 2021
BACKGROUND: Surgical services are preparing to scale up in areas affected by COVID-19. This study aimed to evaluate the association between preoperative SARS-CoV-2 testing and postoperative pulmonary complications in patients undergoing elective cancer sur ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Clin Oncol · January 1, 2021
PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with ...
Full textLink to itemCite
Journal ArticleAm J Surg · November 2020
BACKGROUND: Surgeons face the unique challenge of being responsible for both clinical encounters and surgical outcomes. We aim to explore how patient evaluations of surgeons may be influenced by patient and provider factors. METHODS: Patient responses from ...
Full textLink to itemCite